Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

We compared the risks of switching to another oral anticoagulant (OAC) and discontinuation of direct oral anticoagulants (DOACs) among elderly patients with nonvalvular atrial fibrillation (NVAF) who were prescribed rivaroxaban or dabigatran versus apixaban. Patients (≥65 years of age) with NVAF pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Christine L., Dhamane, Amol D., Rajpura, Jigar, Mardekian, Jack, Dina, Oluwaseyi, Russ, Cristina, Rosenblatt, Lisa, Lingohr-Smith, Melissa, Lin, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829636/
https://www.ncbi.nlm.nih.gov/pubmed/31418293
http://dx.doi.org/10.1177/1076029619870249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829636/
https://www.ncbi.nlm.nih.gov/pubmed/31418293
http://dx.doi.org/10.1177/1076029619870249

Ejemplares similares